EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Disruption of microhomology-mediated end joining in Ewing sarcoma

Shuhei Asada, Guangli Zhu, Jithma Prasad Abeykoon, Yutaro Tanaka, Huy Nguyen, Yuna Hirohashi, Divya R Iyer, Nicholas William Ashton, Sirisha Mukkavalli, Martha Velazquez, Lige Jiang, Miles Del Busso und 7 weitere

Molecular Cell · 2026-08 · 86 (16) · 3167-3184.e12

DOI: 10.1016/j.molcel.2026.06.038 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Cell, 2026-08. Verfasst von Shuhei Asada und 18 weiteren Autor:innen. Beteiligte Einrichtung: Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. …. Hauptthemen laut MEDLINE: Sarcoma, Ewing, RNA-Binding Protein EWS, DNA End-Joining Repair, Proto-Oncogene Protein c-fli-1. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NHLBI NIH HHS, Harvard Medical School Ludwig Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ewing sarcoma (EwS) is a group of bone and soft-tissue cancers in children and young adults. Because EwS cells have pronounced sensitivity to radiation and chemotherapy-induced DNA damage, the oncoprotein EWS-FLI1 is likely to be involved in DNA repair. Here, we demonstrate that EWS-FLI1 causes a defect in microhomology-mediated end joining (MMEJ) repair. EWSR1 is a splicing factor that promotes the faithful splicing of the POLQ pre-mRNA, required for the expression of Polθ, a critical protein in the MMEJ pathway. Expression of EWS-FLI1 or depletion of EWSR1 causes increased POLQ exon 25 skipping, decreased Polθ expression, impaired MMEJ, and enhanced cellular sensitivity to inhibitors of the Fanconi anemia (FA), homologous recombination (HR), or non-homologous end joining (NHEJ) pathways, through the mechanism of synthetic lethality. Correction of POLQ exon 25 skipping restored Polθ expression and MMEJ activity in EwS. Inhibitors of the FA, HR, or NHEJ pathways may therefore provide a targeted therapy for EwS patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sarcoma, EwingRNA-Binding Protein EWSDNA End-Joining RepairProto-Oncogene Protein c-fli-1Oncogene Proteins, FusionBone NeoplasmsHumansDNA Polymerase thetaCell Line, TumorDNA-Directed DNA PolymeraseExonsRNA-Binding ProteinsGene Expression Regulation, NeoplasticRNA Splicing

Stichwörter der Autor:innen

CDK12DNA double-strand breaksDNA-PKcEwing sarcomaRBM39TMEJalternative end joining

Substanzen

RNA-Binding Protein EWSDNA Polymerase thetaProto-Oncogene Protein c-fli-1Oncogene Proteins, FusionDNA-Directed DNA PolymeraseEWS-FLI fusion proteinEWSR1-FLI1 fusion protein, humanRNA-Binding ProteinsEWSR1 protein, human

Autor:innen und Institutionen

  • Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: shuhei_asada@dfci.harvard.edu.
  • Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Department of Radiation Oncology, First Affiliated Hospital of Sun Yat…
  • Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Division of Hematology, Department of Internal Medicine, Mayo Clinic,…
  • Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Harvar…
  • Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

Förderung

  • NCI NIH HHS
  • NHLBI NIH HHS
  • Harvard Medical School Ludwig Center
  • Rally Foundation
  • National Institutes of Health
  • Alex's Lemonade Stand Foundation
  • Japan Society for the Promotion of Science
  • Senshin Medical Research Foundation

Zitieren

APA

Asada, S., Zhu, G., Abeykoon, J. P., Tanaka, Y., Nguyen, H., Hirohashi, Y., Iyer, D. R., Ashton, N. W., Mukkavalli, S., Velazquez, M., Jiang, L., Del Busso, M., Thangaiah, J. J., Robinson, S. I., Parmar, K., Van Allen, E. M., Gillani, R., Shapiro, G. I., & D'Andrea, A. D. (2026). Disruption of microhomology-mediated end joining in Ewing sarcoma. Molecular Cell, 86(16), 3167-3184.e12. https://doi.org/10.1016/j.molcel.2026.06.038

Vancouver

Asada S, Zhu G, Abeykoon JP, Tanaka Y, Nguyen H, Hirohashi Y, et al. Disruption of microhomology-mediated end joining in Ewing sarcoma. Molecular Cell. 2026;86(16):3167-3184.e12. doi:10.1016/j.molcel.2026.06.038

BibTeX
@article{Asada2026,
  author = {Asada, Shuhei and Zhu, Guangli and Abeykoon, Jithma Prasad and Tanaka, Yutaro and Nguyen, Huy and Hirohashi, Yuna and Iyer, Divya R and Ashton, Nicholas William and Mukkavalli, Sirisha and Velazquez, Martha and Jiang, Lige and Del Busso, Miles and Thangaiah, Judith Jebastin and Robinson, Steven I and Parmar, Kalindi and Van Allen, Eliezer M and Gillani, Riaz and Shapiro, Geoffrey I and D'Andrea, Alan D},
  title = {Disruption of microhomology-mediated end joining in Ewing sarcoma},
  journal = {Molecular Cell},
  year = {2026},
  volume = {86},
  number = {16},
  pages = {3167--3184.e12},
  doi = {10.1016/j.molcel.2026.06.038}
}
Kostenlos starten →